http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101257672-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 |
| filingDate | 2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101257672-B1 |
| titleOfInvention | Transmucosal Veterinary Composition |
| abstract | The present invention relates to a pharmaceutical composition of semi-solid form suitable for mucosal administration, which has an effect of sedation, analgesic, inhibition and anxiety in an animal containing detomidine or a pharmaceutically acceptable salt thereof as an active ingredient. In particular, the compositions are in the form of gels or emulsions in the form of mucosal administration.n n n When the semi-solid composition of the present invention is administered to the oral mucosa of large animals such as horses, the expression of the drug is faster than that of intramuscular injection, and has low inflammatory potential on the oral mucosa even after repeated administration. The compositions of the present invention have a longer duration of action than intravenous or intramuscular injection. The present invention thus confers significant advances over any existing method of detomidine administration to large animals such as horses and cattle.n n n n It is therefore an object of the present invention to provide a veterinary veterinary composition in the form of a mucosa semi-solid form comprising detomidine or a pharmaceutically acceptable salt thereof as an active ingredient.n n n Another object of the present invention is to provide a pharmaceutical veterinary composition in the form of a mucosal gel or emulsion containing detomidine or a pharmaceutically acceptable salt thereof as an active ingredient.n n n It is still another object of the present invention to provide a veterinary pharmaceutical composition in the form of a mucosal dosage gel containing detomidine or a pharmaceutically acceptable salt thereof as an active ingredient.n n n Another object of the present invention is to provide a composition comprising: a) a semi-solid composition comprising detomidine or a pharmaceutically acceptable salt thereof as active ingredient, b) a package comprising said composition, and c) a mucosal membrane of said animal. In particular, to provide a veterinary kit containing instructions for administration to the oral mucosa.n n n n A further object of the present invention is to provide a composition comprising: a) a composition in the form of a mucosal gel or emulsion containing detomidine or a pharmaceutically acceptable salt thereof, b) a package comprising the composition, and c) To provide a veterinary kit containing instructions for administering to the mucosa, in particular oral mucosa of the animal.n n n Another object of the present invention is to provide a composition comprising: a) a composition in the form of a mucosal gel containing the detomidine or a pharmaceutically acceptable salt thereof, b) a package comprising the composition, and c) It is to provide a veterinary kit containing instructions for administration to the mucosa, in particular oral mucosa.n n n Another object of the present invention is a veterinary sedation comprising administering to the mucosa of an animal, in particular the oral mucosa, an effective amount of a composition of transmucosal semisolid form containing detomidine or a pharmaceutically acceptable salt thereof as an active ingredient. To provide a way.n n n Another object of the present invention is a method for the preparation of a medicament for administering a composition of transmucosal semi-solid form containing detomidine or a pharmaceutically acceptable salt thereof as an active ingredient to the mucosa of an animal, especially the oral mucosa. To provide.n n n Detomidine, Mucosal Gel |
| priorityDate | 2004-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.